Olanzapine combined with mood stabilizers in prevention of recurrence in bipolar disorder: An 18-month study

被引：0
|
作者：
Tohen, M
Chengappa, KNR
Suppes, T
Baker, RW
Risser, RC
Evans, AR
Calabrese, JR
机构：
[1] Harvard Univ, McLean Hosp, Sch Med, Belmont, MA 02178 USA
[2] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[3] Univ Pittsburgh, Med Ctr, Western Psychiat Inst & Clin, Pittsburgh, PA USA
[4] Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX USA
[5] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA
来源：
BIOLOGICAL PSYCHIATRY | 2003年 / 53卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
381
引用
收藏
页码：134S / 134S
页数：1
相关论文
共 50 条
  • [31] An 18-month study of the effects of IBD symptomatology and emotion regulation on depressed mood
    Inês A. Trindade
    Cláudia Ferreira
    Mariana Moura-Ramos
    José Pinto-Gouveia
    International Journal of Colorectal Disease, 2017, 32 : 651 - 660
  • [32] An 18-month study of the effects of IBD symptomatology and emotion regulation on depressed mood
    Trindade, Ines A.
    Ferreira, Claudia
    Moura-Ramos, Mariana
    Pinto-Gouveia, Jose
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2017, 32 (05) : 651 - 660
  • [33] Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder
    Holm, M.
    Tanskanen, A.
    Lahteenvuo, M.
    Tiihonen, J.
    Taipale, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2022, 61 : 36 - 42
  • [34] Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder
    Holm, M.
    Tanskanen, A.
    Lahteenvuo, M.
    Tiihonen, J.
    Taipale, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2022, 61 : 36 - 42
  • [35] Efficacy of olanzapine for relapse prevention in bipolar disorder
    Tohen, M
    Bowden, C
    Calabrese, J
    Chou, JCY
    Baker, RW
    Williamson, D
    Evans, AR
    ACTA PSYCHIATRICA SCANDINAVICA, 2004, 110 : 38 - 38
  • [36] DOES GUIDELINE-CONCORDANT CARE INFLUENCE 18-MONTH OUTCOMES IN YOUTH WITH BIPOLAR DISORDER?
    Sunder, P.
    Chia, M-F
    Filia, K.
    Davey, C.
    McGorry, P.
    Berk, M.
    Cotton, S.
    Ratheesh, A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (1_SUPPL): : 88 - 89
  • [37] Typology of clinical course in bipolar disorder based on 18-month naturalistic follow-up
    Uher, R.
    Mantere, O.
    Suominen, K.
    Isometsa, E.
    PSYCHOLOGICAL MEDICINE, 2013, 43 (04) : 789 - 799
  • [38] Baseline cognition and 18-month treatment response in young people with bipolar disorder receiving psychotherapy
    Porter, Richard
    Douglas, Katie
    Moot, William
    Crowe, Marie
    Inder, Maree
    Luty, Suzanne
    Carter, Janet
    Frampton, Christopher
    Groves, Samantha
    BIPOLAR DISORDERS, 2023, 25 : 24 - 24
  • [39] Advances in Mood Disorder Pharmacotherapy: Evaluating New Antipsychotics and Mood Stabilizers for Bipolar Disorder and Schizophrenia
    Kowalczyk, Emilia
    Koziej, Sylwia
    Soroka, Ewelina
    MEDICAL SCIENCE MONITOR, 2024, 30
  • [40] Olanzapine and quetiapine in the prevention of a new mood episode in women with bipolar disorder during the postpartum period: a retrospective cohort study
    Uguz, Faruk
    Kirkas, Aysegul
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2021, 43 (06) : 617 - 620
12345